Back

Lower dose direct oral anticoagulation or warfarin in atrial fibrillation. Which one is the best when time on therapeutic range information is available?

18 April 2023 (10:55 - 11:55)
Organised by:
Congress Presentation Part of: Atrial Fibrillation - Round 7 - Stroke - Prevention Stroke in Atrial Fibrillation EHRA Premium Access EHRA 2023

About the speaker

Photo
Mr Alex Luojus

University of Helsinki, Helsinki (Finland)

7 More presentations in this session

Presentation thumbnail
Reduction of major gastrointestinal bleeding risk with proton pump inhibitor therapy in patients with atrial fibrillation receiving direct oral anticoagulant
Doctor S. Lee (Seoul, KR)
Abstract Slides
Presentation thumbnail
Systolic, diastolic blood pressure and pulse pressure and risk of stroke in young aged patients with atrial fibrillation
Doctor S. Lee (Seoul, KR)
Abstract Slides
Presentation thumbnail
Brain lesions and cognitive decline in patients with atrial fibrillation
Doctor E. Hennings (Basel, CH)
Abstract Slides
Presentation thumbnail
Telemedicine: the future of personalised atrial fibrillation care in a post pandemic world?
Doctor I. Koev (Burgas, BG)
Abstract Slides
Presentation thumbnail
Predictive value of left and right atrial strain for the detection of atrial fibrillation in patients with cryptogenic stroke and implant of loop recorder
Doctor G. Arabia (Brescia, IT)
Abstract Slides

Access the full session

Session thumbnail
Atrial Fibrillation - Round 7 - Stroke - Prevention

The Event

Event poster

EHRA 2023

18 April 2023 10:55 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources